BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 24891067)

  • 1. Prucalopride decreases esophageal acid exposure and accelerates gastric emptying in healthy subjects.
    Kessing BF; Smout AJ; Bennink RJ; Kraaijpoel N; Oors JM; Bredenoord AJ
    Neurogastroenterol Motil; 2014 Aug; 26(8):1079-86. PubMed ID: 24891067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sumatriptan, a 5HT1 agonist, on the frequency of transient lower esophageal sphincter relaxations and gastroesophageal reflux in healthy subjects.
    Sifrim D; Holloway RH; Tack J; Zelter A; Missotten T; Coulie B; Janssens J
    Am J Gastroenterol; 1999 Nov; 94(11):3158-64. PubMed ID: 10566707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
    López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
    Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of camicinal, a novel motilin agonist, on gastro-esophageal function in healthy humans-a randomized placebo controlled trial.
    Hobson R; Farmer AD; Dewit OE; O'Donnell M; Hacquoil K; Robertson D; Barton ME; Dukes GE
    Neurogastroenterol Motil; 2015 Nov; 27(11):1629-37. PubMed ID: 26348542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gastric accommodation response to meal intake determines the occurrence of transient lower esophageal sphincter relaxations and reflux events in patients with gastro-esophageal reflux disease.
    Pauwels A; Altan E; Tack J
    Neurogastroenterol Motil; 2014 Apr; 26(4):581-8. PubMed ID: 24533836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of naproxen on gastroesophageal reflux and esophageal function: a randomized, double-blind, placebo-controlled study.
    Scheiman JM; Patel PM; Henson EK; Nostrant TT
    Am J Gastroenterol; 1995 May; 90(5):754-7. PubMed ID: 7733082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a 5-HT(4) receptor agonist on oesophageal function and gastro-oesophageal reflux: studies using combined impedance-manometry and combined impedance-pH.
    Tutuian R; Mainie I; Allan R; Hargreaves K; Agrawal A; Freeman J; Gale J; Castell DO
    Aliment Pharmacol Ther; 2006 Jul; 24(1):155-62. PubMed ID: 16803614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of prucalopride on esophageal secondary peristalsis in reflux patients with ineffective motility.
    Lei WY; Hung JS; Liu TT; Yi CH; Chen CL
    J Gastroenterol Hepatol; 2018 Mar; 33(3):650-655. PubMed ID: 28898473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between acceleration of gastric emptying and oesophageal acid exposure in patients with endoscopy-negative gastro-oesophageal reflux disease.
    Carmagnola S; Fraquelli M; Cantù P; Conte D; Penagini R
    Scand J Gastroenterol; 2006 Jul; 41(7):767-72. PubMed ID: 16785188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of proximal gastric volume on hiatal hernia.
    Scheffer RC; Bredenoord AJ; Hebbard GS; Smout AJ; Samsom M
    Neurogastroenterol Motil; 2010 May; 22(5):552-6, e120. PubMed ID: 20105278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of baclofen on the functional anatomy of the oesophago-gastric junction and proximal stomach in healthy volunteers and patients with GERD assessed by magnetic resonance imaging and high-resolution manometry: a randomised controlled double-blind study.
    Curcic J; Schwizer A; Kaufman E; Forras-Kaufman Z; Banerjee S; Roy S; Pal A; Hebbard GS; Boesiger P; Fried M; Steingoetter A; Schwizer W; Fox M
    Aliment Pharmacol Ther; 2014 Nov; 40(10):1230-40. PubMed ID: 25230154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients.
    Sweis R; Kaufman E; Anggiansah A; Wong T; Dettmar P; Fried M; Schwizer W; Avvari RK; Pal A; Fox M
    Aliment Pharmacol Ther; 2013 Jun; 37(11):1093-102. PubMed ID: 23600790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric emptying and dyspeptic symptoms in patients with gastroesophageal reflux.
    Benini L; Sembenini C; Castellani G; Caliari S; Fioretta A; Vantini I
    Am J Gastroenterol; 1996 Jul; 91(7):1351-4. PubMed ID: 8677993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans.
    Bouras EP; Camilleri M; Burton DD; McKinzie S
    Gut; 1999 May; 44(5):682-6. PubMed ID: 10205205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual site ambulatory pH monitoring: a probe across the lower esophageal sphincter does not induce gastroesophageal reflux.
    Decktor DL; Krawet SH; Rodriguez SL; Robinson M; Castell DO
    Am J Gastroenterol; 1996 Jun; 91(6):1162-6. PubMed ID: 8651164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of gastric emptying on gastro-esophageal reflux: a combined pH-impedance study.
    Gourcerol G; Benanni Y; Boueyre E; Leroi AM; Ducrotte P
    Neurogastroenterol Motil; 2013 Oct; 25(10):800-e634. PubMed ID: 23848571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prucalopride in diabetic and connective tissue disease-related gastroparesis: Randomized placebo-controlled crossover pilot trial.
    Andrews CN; Woo M; Buresi M; Curley M; Gupta M; Tack J; Wilsack L; Nasser Y
    Neurogastroenterol Motil; 2021 Jan; 33(1):e13958. PubMed ID: 32743954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impedance-high resolution manometry analysis of patients with nonerosive reflux disease.
    Ribolsi M; Holloway RH; Emerenziani S; Balestrieri P; Cicala M
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):52-7. PubMed ID: 23891920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of prucalopride on gastric sensorimotor function and satiation in healthy volunteers.
    Carbone F; Vanuytsel T; Tack J
    Neurogastroenterol Motil; 2021 Aug; 33(8):e14083. PubMed ID: 33615630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prucalopride in Gastroparesis: A Randomized Placebo-Controlled Crossover Study.
    Carbone F; Van den Houte K; Clevers E; Andrews CN; Papathanasopoulos A; Holvoet L; Van Oudenhove L; Caenepeel P; Arts J; Vanuytsel T; Tack J
    Am J Gastroenterol; 2019 Aug; 114(8):1265-1274. PubMed ID: 31295161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.